ARCHIVES

Information Lacking On Use, Accuracy Of HER2 Tests

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013

In Surprising Result, Survey Of Centers Finds Little “Crisis” In Clinical Research

September 29, 1995

MSK Starts Ovarian Cancer Program

November 21, 1986

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

DeVita Swearing In Schedule Aug. 8

August 1, 1980

HCT Survivors More Likely To Show Heart Disease Risk Factors

October 26, 2012